Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis
- PMID: 22634354
- DOI: 10.1053/j.gastro.2012.03.055
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis
Comment on
-
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.Gastroenterology. 2012 Feb;142(2):257-65.e1-3. doi: 10.1053/j.gastro.2011.10.032. Epub 2011 Nov 4. Gastroenterology. 2012. PMID: 22062358 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
